A Prospective Study to Establish a New Onset Hyperglycemia and Diabetes (NOD) Cohort

Lead Investigator: Chari, Suresh — The University of Texas MD Anderson Cancer Center

Coordinating Investigator: Feng, Ziding — Fred Hutchinson Cancer Research Center

Involved Investigator Sites:

• Fisher, William — Baylor College of Medicine
• Pandol, Stephen — Cedars Sinai Medical Center
• Feng, Ziding — Fred Hutchinson Cancer Research Center
• Saeed, Zeb — Indiana University
• Van Den Eeden, Stephen — Kaiser Permanente Northern California
• Wu, Bechien — Kaiser Permanente Southern California
• Petersen, Gloria — Mayo Clinic
• Srivastava, Sudhir — National Cancer Institute
• Neidinger, Erik — Frederick National Laboratory for Cancer Research
• Matrisian, Lynn — Pancreatic Cancer Action Network
• Stella, Philip — St. Joseph Mercy Health System
• Park, Walter — Stanford University
• Bradley, David — The Ohio State University Wexner Medical Center
• Maitra, Anirban — The University of Texas M D Anderson Cancer Center
• Chari, Suresh — The University of Texas MD Anderson Cancer Center
• Hughes, Steven — University of Florida
• Brand, Randall E. — University of Pittsburgh
• Cole, John T — Ochsner Medical Center
• Casu, Anna — Advent Health Translational Research Institute
• Rowland, Kendrith — Carle Cancer Center
• Curtis , Amarinthia (Amy) — Gibbs Cancer Center & Research Institute
• Kwon, David S — Henry Ford Health System
• Onitilo, Adedayo A — Marshfield Clinic Health System
• Pisegna, Joseph R — VA Greater Los Angeles Healthcare System

Biomarker Name:

Design: No design specified.

Field(s) of Research: UNKNOWN

Collaborative Group: G.I. and Other Associated Cancers Research Group

Phased Status:

Aims:

Analytic Method:

Comments:

Biomarkers:

There are currently no biomarkers annotated for this protocol.

Datasets:

No datasets are currently associated with this protocol.